A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 Ophthalmic vein thrombosis following Covid

Main Article Content

Irina Panovska-Stavridis
a:1:{s:5:"en_US";s:38:"University Clinic of hematology-Skopje";}

Keywords

COVID, Ophthalmic vein thrombosis, thrombocytopenia

Abstract

x

Downloads

Download data is not yet available.


Abstract 845
PDF Downloads 280
HTML Downloads 316

References

1. WHO. WHO target product profiles for COVID-19 vaccines April 9, 2020. https://www.who.int/publications/m/item/whotarget-product-profiles-for-covid-19-vaccines (accessed, Maj 5, 2021).
2. Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021 J; 397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1.
3. Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021 Apr 9; NEJMoa2104840. doi: 10.1056/NEJMoa2104840
4. Pai M, Chan B, Stall NM, et al. Vaccine-induced immune thrombotic thrombocytopenia (VITT) following adenovirus vector COVID-19 vaccination. Science Briefs of the Ontario COVID-19 Science Advisory Table. 2021;2(17):1-7. https://doi.org/10.47326/ ocsat.2021.02.17.2.0
5. Bayas A, Menacher M2, Christ M, et al. Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination
Lancet 2021 May 1; 397(10285):e11. doi: 10.1016/S0140-6736(21)00872-2.
6. Strobel E. Use of the ID-PaGIA Heparin/PF4 Antibody Test as a screening test for heparin/platelet factor 4 antibodies. Blood Transfus. 2017;15(3):268-271. doi:10.2450/2016.0302-15
7. https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood (accessed, Maj 5, 2021)
8. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/janssen-covid-19-vaccine (accessed, Maj 5, 2021)

Article Sidebar

PDF HTML
Published
Jun 28, 2021
DOI https://doi.org/10.4084/MJHID.2021.048

Article Details

How to Cite

Panovska-Stavridis, I. (2021) “A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: Ophthalmic vein thrombosis following Covid”, Mediterranean Journal of Hematology and Infectious Diseases, 13(1), p. e2021048. doi: 10.4084/MJHID.2021.048.
Issue
Vol. 13 No. 1 (2021): Mediterranean Journal of Hematology and Infectious Diseases, Volume 13, 2021
Section
Letters to the Editor
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.